Press Releases
Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in the Philippines
Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India Pvt. Ltd. (SII), the world's largest vaccine manufacturer by volume, announced that the Philippine Food and Drug Administration...
Press Releases
Turkish Cargo participated in “Logitrans – 2021” fair
The global air cargo brand Turkish Cargo participated this year in Logitrans, Turkey's most extensive international transportation and logistics fair, for the 12th time.
Having a 154 m2 wide stand area in the fair organized in CNR EXPO Istanbul Fair...
Packaging & Labelling
Syntegon enters strategic partnership with Bayer
Syntegon (formerly Bosch Packaging Technology), has entered a strategic partnershop with Bayer for the development of new continuous manufacturing processes for oral solid dosage (OSD) forms. The cooperation is based on the Xelum platform developed by the Syntegon subsidiary...
Press Releases
Roche’s Ronapreve approved by European Commission to treat non-hospitalised COVID-19 patients and for prophylaxis of the disease
Roche announced that the European Commission has granted a marketing authorisation for Ronapreve™ (casirivimab and imdevimab), for treating COVID-19 in adults and adolescents (from 12 years of age and weighing at least 40 kilograms) who do not require supplemental...
Press Releases
Regeneron Antibody Cocktail Approved by European Commission to Treat and Prevent COVID-19
Regeneron Pharmaceuticals, Inc. announced that the EC has approved the casirivimab and imdevimab antibody cocktail, known as REGEN-COV® in the U.S. and Ronapreve™ in the European Union (EU) and other countries. The EC granted marketing authorization for the antibody...
Drug Research
AbbVie, University of Chicago Extend Research Collaboration to Support Preclinical Oncology Research Through 2025
AbbVie and the University of Chicago and have extended their collaboration agreement through 2025 to support preclinical oncology research.
To date, the collaboration has led to novel insights related to biomarkers and therapeutic applications for existing AbbVie programs. This has...
Clinical Trials
Single Dose of Regen-Cov Provides Long-Term Protection Against COVID-19
Single dose of REGEN-COV (1,200 mg subcutaneous) reduced the risk of COVID-19 by 81.6% during the pre-specified follow-up period (months 2-8), maintaining the 81.4% risk reduction previously reported during month 1
During the 8-month assessment period there were 0 hospitalizations...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















